Related Experiment Video
Updated: Mar 1, 2026

08:57
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.7K
Neuroendocrine differentiation in basal cell carcinoma
Yoldez Houcine1, Ines Chelly1, Alia Zehani1
1a Department of Pathology , The La Rabta Hospital, Tunis University , Bab Saadoun, Tunis.
Journal of Immunoassay & Immunochemistry
|May 27, 2017
Summary
Neuroendocrine differentiation is common in basal cell carcinoma (BCC), with Chromogranin A detected in most cases. Synaptophysin expression was less frequent, highlighting varied neuroendocrine markers in BCC.
Area of Science:
- Dermatopathology
- Oncology
- Cell Biology
Background:
- Basal cell carcinoma (BCC) is a common skin cancer with diverse histological patterns.
- BCC can exhibit unusual differentiation, including neuroendocrine features.
- Understanding the frequency of neuroendocrine differentiation in BCC is crucial for accurate diagnosis and potential therapeutic strategies.
Purpose of the Study:
- To determine the relative frequency of neuroendocrine differentiation in basal cell carcinoma.
- To evaluate the expression patterns of neuroendocrine markers in BCC.
Main Methods:
- Retrospective analysis of 33 consecutive basal cell carcinoma (BCC) cases.
- Immunohistochemistry was performed using Chromogranin A and Synaptophysin antibodies.
- Analysis included assessment of staining intensity and cellular localization.
Main Results:
- Chromogranin A was positive in 72.2% (24/33) of BCCs, with varying staining intensity.
- Synaptophysin was positive in 9.09% (3/33) of BCCs.
- Neuroendocrine marker expression was primarily observed in the periphery of the tumors.
Conclusions:
- Neuroendocrine differentiation is a frequent finding in basal cell carcinoma (BCC).
- Chromogranin A is a more sensitive marker for neuroendocrine differentiation in BCC than Synaptophysin.
- These findings contribute to understanding the heterogeneity of BCC and its potential for divergent differentiation.
Related Concept Videos
Skin Cancer
6.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.4K
Cancer Stem Cells and Tumor Maintenance
6.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K

